Close
  Indian J Med Microbiol
 

Figure 3: Cumulative probabilities of developing prostate cancer during follow-up in the participants with baseline prostate-specific antigen levels of 2.0 ng ml−1 or lower (modified from Reference[54]).

Figure 3: Cumulative probabilities of developing prostate cancer during follow-up in the participants with baseline prostate-specific antigen levels of 2.0 ng ml<sup>−1</sup> or lower (modified from Reference<sup>[54]</sup>).